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Objective. To identify the clinical characteristics of a patient population newly diagnosed with acute isolated calf deep venous
thrombosis(ICDVT) by duplex ultrasoundscan (DUS). Methods. A retrospective review of the records of 100 consecutive patients
diagnosedwith ICDVT by DUS wasconducted. Results. Patients (59% male) were predominantlyCaucasian (86%) and inpatients
(69%) with an average age of 53 years. The most frequent risk factors were malignancy (22%), immobility (18%), and previous
DVT (13%). Thrombus was present in named tibial veins in 58% and muscular branches in 42%. The peroneal vein was most
frequently involved (39/117, 33%) followed by the gastrocnemius veins (29/117, 22%) and muscular calf tributaries (14%).
Conclusions. Our patient population with ICDVT was predominantly symptomatic, in-patient cohort with a high incidence of
risk factors such as malignancy, immobility, previous DVT, trauma, and postoperative status. Partial or complete resolution was
documented by DUS in 53%.
1.Introduction
Deep venous thrombosis (DVT) of the lower limb poses a
signiﬁcant threat to patients’ lives each year with more than
100,000casesreportedannuallyandisrelatedtoover200,000
hospitalizations each year in the United States [1]. Although
proximal DVT is associated with a much greater incidence
of pulmonary embolism, the entirely benign nature of
isolated calf deep vein thrombosis (ICDVT) as summarized
by Philbrick and Becker in 1988 has been largely disproved
[2].
Although the natural history of ICDVT, the propagation
rate, and incidence of PE have been documented, the
patientpopulationinthesereportshasbeenextremely varied
and documented prior to aggressive anticoagulation. We
therefore sought to deﬁne the clinical characteristics of a
predominantly inpatient population with newly diagnosed
ICDVT by duplex ultrasound performed in a large teaching
hospital.
2.Methods
One hundred consecutive patients with newly diagnosed
acute ICDVT by DUS in the Vascular Laboratory at The
Ohio State University Medical Center beginning in July 1st
2006 were part of this retrospective study. We excluded ﬁve
patientswithincompleterecordsleaving95patientswith119
ICDVTs. Allpatientswithahistory ofpriorICDVTwere also
excluded. Demographic information including risk factors,
treatment, and followup was obtained from Vascular Labo-
ratory records and the Information Warehouse. Data were
analyzed using Microsoft Excel (Microsoft Corp, Redmond,
Wash).
Duplex scanning was performed by registered vascu-
lar technologists in an ICAVL accredited laboratory. The
ultrasound machines used were a General Electric Logiq 9
(GE Healthcare Technologies: Waukesha, Wisconsin, USA),
Philips iU 22s (Philips Healthcare: Bothell, WA USA), and
a Zonare Zone system (Zonare Inc: Mountain View, CA).2 International Journal of Vascular Medicine
Scanning technique is performed in a standard fashion with
compression using grey-scale transverse scanning and color
imaging utilizing both transverse and longitudinal planes.
Calf veins are imaged as above from the knee to the ankle
in both transverse and longitudinal planes. The location of
the thrombus but not the length was noted.
This study was approved by the Institutional Review
Board at the Ohio State University Medical Center.
3.Results
Duringtheeight-monthstudyperiod,therewere 4,276lower
extremity venous DUSs performed on 7,126 limbs. Of these
exams, 875 scans resulted in a diagnosis of acute or chronic
DVT including the 100 patients diagnosed with ICDVT. The
average age of the patient population was 53 years. Just over
half of the patients were male (59%; 56/95) and 86% (82/95)
were Caucasian. Approximately 69% (66/95) of the ICDVTs
were diagnosed during an inpatient admission.
The most common indication for requesting the DUS
was edema (28%) (Table 1). Eleven patients had a recent
diagnosis of a pulmonary embolus which led to the duplex
examination.
Risk factors and comorbidities are shown in Table 2.I n
the study population, diabetes mellitus (25%) and acute
or chronic renal failure (18%) were the most common
comorbidities. As would be expected in a large inpatient
population, malignancy (20%), immobility (18%), and
previous proximal DVT (13%) were frequent risk factors.
Table 3 outlines the location of the ICDVTs diagnosed by
DUS. Both lower extremities were aﬀected in nine percent.
The most commonly involved calf vein was the peroneal vein
(32%) followed by the gastrocnemius vein (22%). Named
t i b i a lv e i n sw e r ei n v o l v e di n5 8 %a n dm u s c u l a rb r a n c h e si n
42% (Table 3).
While long-term followup and treatment were not the
focus of this study, at least one followup DUS venous exam
was completed in 41 of the 95 patients (43%) (Table 4).
Eighteen of the 41 patients (44%) demonstrated no change
in the ICDVT. Lysis was seen in 53% with 16 (39%) showing
partial recanalization of the aﬀected vein, and 7 (17%) had
evidence of complete resolution of the thrombus at a mean
followup interval of 39 days (range 1, 180). Nineteen (20%)
patients underwent a second followup duplex exam at an
average of 107 days from their original diagnosis (range 4,
631). Equal numbers of patients demonstrated no change
in the DVT and complete recanalization (37%). A third
followup ultrasound exam was completed on 8 patients, all
but one of these failed to reveal any change in the thrombus.
No progression was noted in any patient that had
a followup DUS.
4.Discussion
We report on a large series of patients with newly diagnosed
ICDVT and identify and compare the principal character-
istics of this patient population to other similar reports
[3–8]. The majority of patients, identiﬁed in this study
Table 1: Indications for duplex scan.
N Percent
Pain/Edema 20 21
Pain 21 22
Edema 27 28
Respiratory distress 13 14
Suspected pulmonary embolus 11 12
Screening after immobility 2 2
Acute stroke 1 1
Table 2: Comorbidities and risk factors.
Comorbidities N Percent
Cancer 19 20
Immobility 17 18
Previous thigh DVT 12 13
Postoperative/Trauma 14 14
Hypercoagulable state 2 2
Hypertension 11 12
Patent foramen ovale 1 1
Pregnancy 1 1
Acute CVA 1 1
Varicosities 1 1
Diabetes mellitus 24 25
Lymphoma 2 2
Renal failure 16 17
Chronic 7 7
Acute 9 9
Table 3: Locationof calf DVTs.
Location N Percent
Right 66 55
Left 42 35
Bilateral 11 9
Muscular calf vein 16 13
Anterior tibial vein 0 0
Posterior tibial vein 17 14
Peroneal vein 39 32
Gastrocnemius vein 26 22
Soleal vein 7 6
Tibial trunk 12 10
through a query of our vascular laboratory database, were
inpatient with an average age of 53 years. Since 69% of
patients in our cohort were inpatients, the risk factors were
expectedly malignancy (19%), immobilization (18%), and
postoperative or trauma patients (14%). This is similar to
other reports in the literature [9].
The prevalence of ICDVT depends on whether the pop-
ulation being studied is asymptomatic and being screened
or symptomatic. In symptomatic patients, the prevalence
of ICDVT is reported as being 5–12%, and for high riskInternational Journal of Vascular Medicine 3
Table 4: Followup.
N Percent
First followup 41 43
Interval
Mean 39
Median 13
Mode 7
Range 1, 180
Second followup 19 20
Interval
Mean 107
Median 51
Mode n/a
Range 4, 631
Third followup 8 8
Interval
Mean 125
Median 130
Mode n/a
Range 7, 227
Fourth followup 1 1
Interval 14
groups undergoing screening following joint replacement,
for instance, it is 15% or higher [10, 11]. As pointed
out, almost two-thirds of patients in this series were inpa-
tients (and all symptomatic) even though the inpatient to
outpatient ratio in our laboratory is approximately equal. In
t h es a m et i m ef r a m ea so u rs t u d y ,t h ei n c i d e n c eo fap o s i t i v e
DUS study (acute or chronic DVT) was 20% (875/4276),
and the incidence of ICDVT was 2.3% (100/4276). ICDVT
represented 11.4% of all positive DUS studies in the same
time period.
The usual DUS of the calf performed to detect DVT
consists of scanning the paired posterior tibial, peroneal, and
anterior tibial veins. In addition, the nonpaired muscular
veins (gastrocnemial and soleal) are also imaged. Most
studies, like ours, report the peroneal vein as the most
common site of ICDVT although some have reported that
the site and size of thrombosis do not diﬀer signiﬁcantly
amongst the calf veins [4]. The rarity of involvement of the
anterior tibial vein in patients with ICDVT is conﬁrmed
in our study. Masuda et al. noted that of 58 limbs in
54 patients, 12% had gastrocnemius vein involvement and
0% anterior tibial vein involvement, similar to our results
[3]. For this reason, some vascular laboratories may not
even scan the anterior tibial vein in patients referred for a
lower extremity DUS. Mattos et al. reviewed 655 limbs with
DVT and concluded that, while calf veins should always be
assessed when performing a lower extremity duplex exam,
the anterior tibial veins may not necessarily be visualized as
the incidence of thrombosis is negligible [7]. The incidence
of muscular vein thrombosis in the calf varies from 12.5 to
15% [5].
The immediate and late consequences of ICDVT have
been debated for many years. Propagation into the proximal
larger veins and pulmonary embolism is of great clinical
relevance because these events require aggressive anticoag-
ulation even by clinicians who prefer not to treat patients
with ICDVT. Labropoulos et al. found propagation of a calf
clot in 27% and an incidence of pulmonary embolus in 2%
in a series of 52 limbs with ICDVT [4]. A series by Gillet
et al. reported a 7% incidence of pulmonary embolus from
ICDVT [5]. Still others have reported similar ﬁndings of
proximal propagation rates of ICDVTs [12]. Despite treat-
ment with anticoagulants, there are reports of propagation
of the thrombus in patients with ICDVT. Labropoulos et al.
reported a 13% propagation rate of ICDVTs to the proximal
venous system [4]. However, Parisi and colleagues showed
evidence of propagation into the popliteal or thigh veins of
only 2.9% of ICDVTs [13]. Interestingly, in Kazmers et al.’s
review of over 3000 patients, those who were found to have
propagation of a calf DVT were more likely to have cancer
than not (35% versus 7.8%) [9]. We did not detect any
propagationinthe41patientswithICDVTinourserieswith
theﬁrst followupDUSperformed atanaverageof39days.In
addition, although this was not a prospective series nor were
patients subjected to routine ventilation/perfusion scans, no
pulmonary embolic episodes were recorded in the medical
record.
Besidesproximalpropagationand pulmonary embolism,
long-term chronic reﬂux has also been documented after
ICDVT. A 1998 study reported that 4% of patients experi-
enced propagation of the calf vein thrombosis into the more
proximal popliteal or thigh veins and 30% of patients devel-
oped venous reﬂux disease [3]. Meissner et al. corroborated
these ﬁndings by demonstrating a 24% incidence of venous
reﬂux disease at one-year followup in their study population
withICDVTs[6].OurfollowupbyDUSwasnotlongenough
to comment on late chronic venous disease.
Limitations. Aside from the retrospective nature of our
study, the lack of followup beyond what was available in
hospital records and on repeat ultrasound reports restricts
us from reporting on the late natural history of ICDVT. In
addition, we do not have data on the duration or the type
of anticoagulant therapy, making it impossible to report on
a correlation between the resolution of the thrombus and
anticoagulant therapy.
Spontaneous lysis of thrombus generally occurs within
the ﬁrst six weeks following diagnosis of DVT [14]. Masuda
and Meissner report lysis in patients with ICDVT in over
50%ofpatientswithinthree months. Althoughourfollowup
interval was relatively short, 54% either resolved completely
(17%) or partially (39%) whereas 44% demonstrated no
change. The critical dilemma for clinicians is the inability
to tailor the duration and intensity of anticoagulation
to the probability and speed of thrombus resolution. As
Labropoulosand colleaguespointout,thrombusremodeling
does seem to be correlated with the size, location, and
pattern of thrombosis [4]. Techniques that measure the
actual thrombus load, rather than the location or extent
of thrombus, may provide more objective information on
which to base clinical decisions upon [15].4 International Journal of Vascular Medicine
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